表紙
市場調査レポート

MediPoint:核磁気共鳴画像(MRI)装置−−アジア太平洋地域市場の分析と予測

MediPoint: Magnetic Resonance Imaging Systems - APAC Analysis and Market Forecasts

発行 GlobalData 商品コード 322143
出版日 ページ情報 英文 167 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
MediPoint:核磁気共鳴画像(MRI)装置−−アジア太平洋地域市場の分析と予測 MediPoint: Magnetic Resonance Imaging Systems - APAC Analysis and Market Forecasts
出版日: 2014年12月31日 ページ情報: 英文 167 Pages
概要

世界のMRI(核磁気共鳴画像)市場は変革期の只中にあり、ことに資本設備市場は飽和状態に達し、多数の企業が革新的製品を開発しています。他方、MRIはその登場以来、安全性・効率性の高さや非侵襲的手法が評価されて、導入規模が拡大し続けています。画像技術の急速な進歩や安全技術の発展が、潜在的な治療対象領域の拡大につながってきました。日本の場合、全ての製品分野で将来的な市場成長が見込まれており、他の国々では市場規模が縮小している低磁場MRIでも成長が生じるものと思われます。中国でも全部門で市場成長が見込まれていますが、低磁場MRIの場合は年平均成長率(CAGR)1%程度の低順に留まる見通しです。インドでは、低磁場MRI市場のCAGRはマイナス0.6%と、むしろ微減傾向が予想されています。

当レポートでは、アジア太平洋地域諸国の核磁気共鳴画像(以下MRI)装置市場について分析し、装置の技術的特性や市場構造、現在のアンメットニーズ、主な市場促進・抑制要因、今後の市場機会、現在開発中の主要製品、地域全体および主要国における市場動向(過去3年間の実績値と今後7年間の予測値)、製品カテゴリー別の詳細動向、主要企業のプロファイルなどを調査しております。

第1章 目次

第2章 イントロダクション

第3章 産業概要

  • MRI技術の概要
  • システム概要
    • 前分極MRIシステム
    • 拡散MRI
    • みかけの拡散係数
  • 技術の活用分野
  • MRI検査の臨床上の適応
  • 処置の動向
    • 製品のライフサイクル
  • 技術の利点・欠点
    • 概要
    • MRI技術のSWOT分析
    • MRI装置に関する閉所恐怖症の問題
    • 磁気共鳴画像(MRI) vs. コンピュータ断層撮影(CT)
  • 市場へのアクセス
    • 製品のライフサイクル
    • 購入意思決定
    • 一括購買組織の役割
  • 規制プロセス
  • 現在のMRIの医療費償還の動向
  • 処置の動向
    • 神経学
    • 四肢MRI
    • PET/MRI
    • アジア太平洋地域
    • 磁気共鳴血管造影
    • 磁気共鳴スペクトル測定
    • 運用時間
    • 規制上の課題/リコール
  • 経済的影響
    • 直接的な費用
    • MRIシステムの価格

第4章 アンメットニーズ

  • 概要
  • 被験者データの保管・管理
  • マルチパラメーターMRI
  • 被験者の快適性にすぐれた、静粛性の高いシステム
  • 高度画像取込ハードウェアのサポート用ソフトウェアの改善
  • スループットの高速化
  • 被験者の快適性の改善

第5章 市場機会の分析

  • 概要
  • スキャンの標準化
  • 各種病院へのMRI導入件数の拡大
  • 心臓用MRIの普及
  • 脳発達研究における高磁場MRI
  • 電力供給が不安定な場合は依然として望ましい永久磁石
  • 脳腫瘍の画像化
  • 冷凍剤フリーの冷却システム
  • 外来検査用の追加スキャナ
  • 乳がん・前立腺がん用MRI
  • がん向け全身MRI
  • クラウドコンピューティングの発達
  • 脳外傷の診断速度を速めるための新技術

第6章 市場促進要因および障壁

  • 概要
  • 促進要因:より高い磁場での画像取込能力の改善
  • 促進要因:老朽化装置からの低画質画像
  • 促進要因:MRI装置の平均年数の古さ
  • 促進要因:老朽化装置からの同質信号取得の難しさ
  • 障壁:機械操作訓練のためのリソースの少なさ
  • 障壁:経済的圧力による新規装置導入規模の縮小
  • 障壁:システムの誤用
  • 障壁:MRIシステムの酷使
  • 障壁:ISO(独立系サービス組織):メーカーからのサービス・新規製品販売に取って代わる割安な代替手段
  • 障壁:超伝導MRI磁石メーカー
  • 障壁:MRI処置への医療費償還額の不均一性

第7章 競合評価

  • 主な製品の完全プロファイル
    • Oasis (日立メディコ)
    • Echelon Oval (日立メディコ)
    • Discovery MR750w (GE Healthcare)
    • Optima MR360 Advance (GE Healthcare)
    • Optima MR450w (GE Healthcare)
    • Signa HDxt (GE Healthcare)
    • Vantage Titen (Philips Healthcare)
    • Ingenia (Philips Healthcare)
    • Achieva TX (Philips Healthcare)
    • Magnetom Aera (Siemens Healthcare)
    • Magnetom C! (Siemens Healthcare)
    • Magnetom Spectra (Siemens Healthcare)
    • NSM-S15 (Neusoft Medical Systems)
  • 磁力の強さに基づく分類
    • 低磁場MRI装置
    • 中磁場MRI装置
    • 高磁場MRI装置

第8章 パイプライン評価

  • 11.7T MRI Sytem (Neurospin)
  • Aurora PET/MRI System (Aurora Imaging Technology)
  • Neona (Time Medical)
  • GE 7.0T MRI Scanner (GE Healthcare)
  • Signa PET/MRI (GE Healthcare)

第9章 現在および将来の主要企業

  • 概要
  • Aurora Imaging
  • China Resources Wandong Medical Equipment
  • Esaote S.p.A.
  • Fonar Corporation
  • GE Healthcare
  • 日立メディコ
  • Hologic
  • Mindray
  • Neusoft Medical
  • Ningbo Xingaoyi Medical
  • Philips Healthcare
  • Siemens Healthcare
  • Time Medical
  • 東芝メディカルシステムズ

第10章 戦略的な競合評価

  • 企業別の市場シェア

第11章 市場の展望:市場区分別

  • 国別の市場内訳

第12章 市場の展望:地域別

  • APAC(アジア太平洋地域)
    • APACの市場シェア:国別
    • APAC市場の規模:市場区分別
  • 日本
  • 中国
  • インド

第13章 付録

図表一覧

目次
Product Code: GDME1123CFR

The global magnetic resonance imaging (MRI) market is a shifting, capital equipment market that is saturated with numerous players developing innovative technologies. Given their impressive safety and efficacy as well as non-invasive nature, MRI systems have seen continued adoption since they were first introduced to the healthcare market. Rapid advances in the field imaging along with the development of MRI safe technologies have greatly expanded the potential of therapeutic applications.

All MRI markets in Japan are expected to experience growth through 2020, including low-field systems, which are declining in many other countries globally. All MRI market segments will experience growth in China during the forecast period, although low-field systems will grow at a small CAGR of 1.0%. In India, the low-field strength MRI market segment will decline slightly at a negative CAGR of 0.6% through 2020,

Scope

  • An overview of Magnetic Resonance Imaging Systems, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized the APAC Magnetic Resonance Imaging Systems market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
  • Investigation of current and future market competition for Magnetic Resonance Imaging Systems.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the Magnetic Resonance Imaging Systems sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

  • Understand the trends shaping and driving the APAC Magnetic Resonance Imaging Systems market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in the APAC Magnetic Resonance Imaging Systems market through 2018.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in the APAC Magnetic Resonance Imaging Systems market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Overview of MRI Technology
  • 3.2. System Overview
    • 3.2.1. Pre-Polarizing MRI Systems
    • 3.2.2. Diffusion MRI
    • 3.2.3. Apparent Diffusion Coefficient
  • 3.3. Applications of Technology
  • 3.4. Clinical Indications for MRI scans
  • 3.5. Procedure Trends
    • 3.5.1. Product Lifecycle
  • 3.6. Advantages and Disadvantages of Technology
    • 3.6.1. Overview
    • 3.6.2. MRI Technology SWOT Analysis
    • 3.6.3. Claustrophobia Issues with MRI Systems
    • 3.6.4. Magnetic Resonance Imaging vs. Computed Tomography
  • 3.7. Market Access
    • 3.7.1. Product Life Cycle
    • 3.7.2. Purchasing Decisions
    • 3.7.3. Role of Group Purchasing Organizations
  • 3.8. Regulatory Process
    • 3.8.1. Japan
    • 3.8.2. China
    • 3.8.3. India
  • 3.9. Current MRI Reimbursement Trends
    • 3.9.1. Japan
    • 3.9.2. China
    • 3.9.3. India
  • 3.10. Procedure Trends
    • 3.10.1. Neurology
    • 3.10.2. Extremity MRI
    • 3.10.3. PET/MRI
    • 3.10.4. Asia-Pacific
    • 3.10.5. Magnetic Resonance Angiography
    • 3.10.6. Magnetic Resonance Spectroscopy
    • 3.10.7. Hours of Operation
    • 3.10.8. Regulatory Issues/Recalls
  • 3.11. Economic Impact
    • 3.11.1. Direct Costs
    • 3.11.2. Pricing of MRI Systems

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Storing and Managing Patient Data
  • 4.3. Multiparametric MRI
  • 4.4. Quieter Systems for Improved Patient Comfort
  • 4.5. Improved Software to Support Advanced Image Acquisition Hardware
  • 4.6. Faster Throughput
  • 4.7. Improvements in Patient Comfort

5. Market Opportunity Analysis

  • 5.1. Overview
  • 5.2. Standardization of Scans
  • 5.3. Increased Adoption of MRI Throughout the Hospital
  • 5.4. Cardiac MRI on the Rise
  • 5.5. High-Field MRI in Developing Brains
  • 5.6. Permanent Magnets Still Desirable Where Power Unreliable
  • 5.7. Imaging Brain Tumors
  • 5.8. Cryogen-Free Cooling Systems
  • 5.9. Additional Scanners for Outpatient Exams
  • 5.10. Breast and Prostate Cancer MRI
  • 5.11. Whole-Body MRI for Cancer
  • 5.12. Cloud Computing on the Rise
  • 5.13. New MRI Technique to Speed Up Diagnosis for Traumatic Brain Injury

6. Market Drivers and Barriers

  • 6.1. Overview
  • 6.2. Driver: Improved Imaging Capabilities of Higher Field Strength
  • 6.3. Driver: Low-Quality Images from Older Machines
  • 6.4. Driver: High Average Age of MRI Systems
  • 6.5. Driver: Difficulty of Achieving Homogenous Signals with Older Systems
  • 6.6. Barrier: Fewer Resources for Training on Machines
  • 6.7. Barrier: Economic Pressure Reduces New Systems Volume
  • 6.8. Barrier: Misuse of Systems
  • 6.9. Barrier: Overuse of MRI Systems
  • 6.10. Barrier: ISOs a Cheaper Alternative to Service or New Sales from OEM
  • 6.11. Barrier: Supeconducting MRI Magnet Producers
  • 6.12. Barrier: Uneven Reimbursement for MRI Procedures

7. Competitive Assessment

  • 7.1. Full Profiles for Key Products
    • 7.1.1. Oasis (Hitachi)
    • 7.1.2. Echelon Oval (Hitachi)
    • 7.1.3. Discovery MR750w (GE Healthcare)
    • 7.1.4. Optima MR360 Advance (GE Healthcare)
    • 7.1.5. Optima MR450w (GE Healthcare)
    • 7.1.6. Signa HDxt (GE Healthcare)
    • 7.1.7. Vantage Titen (Philips Healthcare)
    • 7.1.8. Ingenia (Philips Healthcare)
    • 7.1.9. Achieva TX (Philips Healthcare)
    • 7.1.10. Magnetom Aera (Siemens Healthcare)
    • 7.1.11. Magnetom C! (Siemens Healthcare)
    • 7.1.12. Magnetom Spectra (Siemens Healthcare)
    • 7.1.13. NSM-S15 (Neusoft Medical Systems)
  • 7.2. Classification Based on Field Strength
    • 7.2.1. Low-Field MRI Systems
    • 7.2.2. Mid-Field MRI Systems
    • 7.2.3. High-Field MRI Systems

8. Pipeline Assessment

  • 8.1. 11.7T MRI System (Neurospin)
    • 8.1.1. Overview
    • 8.1.2. SWOT
  • 8.2. Aurora PET/MRI System (Aurora Imaging Technology)
    • 8.2.1. Overview
    • 8.2.2. SWOT
  • 8.3. Neona (Time Medical)
    • 8.3.1. Overview
    • 8.3.2. SWOT
  • 8.4. GE 7.0T MRI Scanner (GE Healthcare)
    • 8.4.1. Overview
    • 8.4.2. SWOT
  • 8.5. Signa PET/MRI (GE Healthcare)
    • 8.5.1. Overview
    • 8.5.2. SWOT

9. Current and Future Players

  • 9.1. Overview
  • 9.2. Aurora Imaging
    • 9.2.1. Overview
    • 9.2.2. Portfolio Assessment

9.2.3. SWOT Analysis

  • 9.3. China Resources Wandong Medical Equipment
    • 9.3.1. Overview
    • 9.3.2. Portfolio Assessment
    • 9.3.3. SWOT Analysis
  • 9.4. Esaote S.p.A.
    • 9.4.1. Overview
    • 9.4.2. Portfolio Assessment
    • 9.4.3. SWOT Analysis
  • 9.5. Fonar Corporation
    • 9.5.1. Overview
    • 9.5.2. Portfolio Assessment
    • 9.5.3. SWOT Analysis
  • 9.6. GE Healthcare
    • 9.6.1. Overview
    • 9.6.2. Portfolio Assessment
    • 9.6.3. SWOT Analysis
  • 9.7. Hitachi Medical Corporation
    • 9.7.1. Overview
    • 9.7.2. Portfolio Assessment
    • 9.7.3. SWOT Analysis
  • 9.8. Hologic
    • 9.8.1. Overview
    • 9.8.2. Portfolio Assessment
    • 9.8.3. SWOT Analysis
  • 9.9. Mindray
    • 9.9.1. Overview
    • 9.9.2. Portfolio Assessment
    • 9.9.3. SWOT Analysis
  • 9.10. Neusoft Medical
    • 9.10.1. Overview
    • 9.10.2. Portfolio Assessment
    • 9.10.3. SWOT Analysis
  • 9.11. Ningbo Xingaoyi Medical
    • 9.11.1. Overview
    • 9.11.2. Portfolio Assessment
    • 9.11.3. SWOT Analysis
  • 9.12. Philips Healthcare
    • 9.12.1. Overview
    • 9.12.2. Portfolio Assessment
    • 9.12.3. SWOT Analysis
  • 9.13. Siemens Healthcare
    • 9.13.1. Overview
    • 9.13.2. Portfolio Assessment
    • 9.13.3. SWOT Analysis
  • 9.14. Sina Healthcare
    • 9.14.1. Overview
    • 9.14.2. Portfolio Assessment
    • 9.14.3. SWOT Analysis
  • 9.15. Time Medical
    • 9.15.1. Overview
    • 9.15.2. Portfolio Assessment
    • 9.15.3. SWOT Analysis
  • 9.16. Toshiba Medical Systems Corporation
    • 9.16.1. Overview
    • 9.16.2. Portfolio Assessment
    • 9.16.3. SWOT Analysis

10. Stategic Competitive Assessment

  • 10.1. Company Market Share
    • 10.1.1. APAC
    • 10.1.2. Japan
    • 10.1.3. China
    • 10.1.4. India

11. Market Outlooks by Market Segment

  • 11.1. Market Segment by Country
    • 11.1.1. Japan
    • 11.1.2. China
    • 11.1.3. India

12. Market Outlooks by Geography

  • 12.1. APAC
    • 12.1.1. APAC Market Share by Country
    • 12.1.2. APAC Market Value by Market Segment
  • 12.2. Japan
    • 12.2.1. Market Value by Market Segment
    • 12.2.2. Installed Base of MRI Systems
  • 12.3. China
    • 12.3.1. Market Value by Market Segment
    • 12.3.2. Installed Base of MRI Systems
  • 12.4. India
    • 12.4.1. Market Value by Market Segment
    • 12.4.2. Installed Base of MRI Systems

13. Appendix

  • 13.1. Bibliography
  • 13.2. Abbreviations
  • 13.3. Report Methodology
    • 13.3.1. Overview
    • 13.3.2. Coverage
    • 13.3.3. Secondary Research
  • 13.4. Forecasting Methodology
  • 13.5. Primary Research - Key Opinion Leaders
  • 13.6. Primary Research - Physician and Industry Overviews
    • 13.6.1. Expert Panel Validation
  • 13.7. Physicians & Experts Included in this Study
  • 13.8. About the Authors
    • 13.8.1. Analysts
    • 13.8.2. Global Head of Healthcare
  • 13.9. About MediPoint
  • 13.10. About GlobalData
  • 13.11. Disclaimer

List of Tables

  • Table 1: MRI Procedure Targets
  • Table 2: Indications for an Immediate Emergency MRI
  • Table 3: Advantages and Disadvantages of MRI
  • Table 4: Magnetic Resonance Imaging Technology SWOT Analysis
  • Table 5: Selected Group Purchasing Organizations in the US and EU
  • Table 6: Japan Average Selling Price by Market Segment (2011-2020), $m
  • Table 7: China Average Selling Price by Market Segment (2011-2020), $m
  • Table 8: India Average Selling Price by Market Segment (2011-2020), $m
  • Table 9: MRI Applications and Future Market Potential
  • Table 10: SWOT Analysis - Oasis
  • Table 11: SWOT Analysis - Echelon Oval
  • Table 12: SWOT Analysis - Discovery MR750w
  • Table 13: SWOT Analysis - Optima MR360 Advance
  • Table 14: SWOT Analysis - Optima MR450w
  • Table 15: SWOT Analysis - Signa HDxt
  • Table 16: SWOT Analysis - Vantage Titen
  • Table 17: SWOT Analysis - Ingenia
  • Table 18: SWOT Analysis - Achieva TX
  • Table 19: SWOT Analysis - Magnetom Aera
  • Table 20: SWOT Analysis - Magnetom C!
  • Table 21: SWOT Analysis - Magnetom Spectra
  • Table 22: SWOT Analysis - NSM-S15
  • Table 23: SWOT Analysis - Low-Field MRI Systems
  • Table 24: Low-Field MRI Systems
  • Table 25: SWOT Analysis - Mid-Field MRI Systems
  • Table 26: Mid-Field MRI Systems
  • Table 27: SWOT Analysis - High-Field MRI Systems
  • Table 28: High-Field MRI Systems
  • Table 29: SWOT Analysis - 11.7T MRI (Neurospin)
  • Table 30: SWOT Analysis - Aurora PET/MRI System (Aurora Imaging Technology)
  • Table 31: SWOT Analysis - Neona (Time Medical)
  • Table 32: SWOT Analysis - 7.0T MRI Scanner (GE Healthcare)
  • Table 33: SWOT Analysis - Signa PET/MR (GE Healthcare)
  • Table 34: Company Profile - Aurora Imaging
  • Table 35: Aurora Imaging, MRI System Device Portfolio
  • Table 36: SWOT Analysis - Aurora Imaging
  • Table 37: Company Profile - China Resources Wandong Medical Equipment
  • Table 38: China Resources Wandong Medical Equipment, MRI System Device Portfolio
  • Table 39: SWOT Analysis - China Resources Wandong Medical Equipment
  • Table 40: Company Profile - Esaote S.p.A.
  • Table 41: Esaote S.p.A., MRI System Device Portfolio
  • Table 42: SWOT Analysis - Esaote S.p.A.
  • Table 43: Company Profile - Fonar Corporation
  • Table 44: Fonar Corporation, MRI System Device Portfolio
  • Table 45: SWOT Analysis - Fonar Corporation
  • Table 46: Company Profile - GE Healthcare
  • Table 47: GE Healthcare, MRI System Device Portfolio
  • Table 48: SWOT Analysis - GE Healthcare
  • Table 49: Company Profile - Hitachi Medical Corporation
  • Table 50: Hitachi Medical Corporation, MRI System Device Portfolio
  • Table 51: SWOT Analysis - Hitachi Medical
  • Table 52: Company Profile - Hologic
  • Table 53: SWOT Analysis - Hologic
  • Table 54: Company Profile - Mindray
  • Table 55: Mindray, MRI System Device Portfolio
  • Table 56: SWOT Analysis - Mindray
  • Table 57: Company Profile - Neusoft Medical
  • Table 58: Neusoft Medical, MRI System Device Portfolio
  • Table 59: SWOT Analysis - Neusoft Medical
  • Table 60: Company Profile - Ningbo Xingaoyi Medical
  • Table 61: Ningbo Xingaoyi Magnetism, MRI System Device Portfolio
  • Table 62: SWOT Analysis - Ningbo Xingaoyi Magnetism
  • Table 63: Company Profile - Philips Healthcare
  • Table 64: Philips Healthcare, MRI System Device Portfolio
  • Table 65: SWOT Analysis - Philips Healthcare
  • Table 66: Company Profile - Siemens Healthcare
  • Table 67: Siemens Healthcare, MRI System Device Portfolio
  • Table 68: SWOT Analysis - Siemens Healthcare
  • Table 69: Company Profile - Sina Healthcare
  • Table 70: Sina Healthcare, MRI System Device Portfolio
  • Table 71: SWOT Analysis - Sina Healthcare
  • Table 72: Company Profile - Time Medical
  • Table 73: Time Medical, MRI System Device Portfolio
  • Table 74: SWOT Analysis - Time Medical
  • Table 75: Company Profile - Toshiba
  • Table 76: Toshiba, MRI System Device Portfolio
  • Table 77: SWOT Analysis - Toshiba
  • Table 78: APAC Market Sales for MRI Systems (2012)
  • Table 79: Japan Market Sales for MRI Systems (2012)
  • Table 80: China Market Sales for MRI Systems (2012)
  • Table 81: India Market Sales for MRI Systems (2012)
  • Table 82: Japan Market Segment, 2012 & 2020
  • Table 83: China Market Segment, 2012 & 2020
  • Table 84: India Market Segment, 2012 & 2020
  • Table 85: APAC Market by Country, 2012 & 2020
  • Table 86: APAC Market Value by Market Segment for MRI Systems (2011-2020), $m
  • Table 87: Japan Market Value Forecast by Market Segment (2011-2020), $m
  • Table 88: Japan Installed Base of MRI Systems (2011-2020)
  • Table 89: China Market Value Forecast by Market Segment (2011-2020), $m
  • Table 90: China Installed Base of MRI Systems (2011-2020)
  • Table 91: India Market Value Forecast by Market Segment (2011-2020), $m
  • Table 92: India Installed Base of MRI Systems (2011-2020)
  • Table 93: Primary Research Interviews Completed by Country
  • Table 94: Primary Research Interviews Completed by Designation

List of Figures

  • Figure 1: Japan Average Selling Price by Market Segment
  • Figure 2: China Average Selling Price by Market Segment
  • Figure 3: India Average Selling Price by Market Segment
  • Figure 4: Average Age for Magnetic Resonance Imaging Machines in 5EU in 2013
  • Figure 5: APAC Market Share for MRI Systems (2012)
  • Figure 6: Japan Market Share for MRI Systems (2012)
  • Figure 7: China Market Share for MRI Systems (2012)
  • Figure 8: India Market Share for MRI Systems (2012)
  • Figure 9: Japan Market Segment, 2012 & 2020
  • Figure 10: China Market Segment, 2012 & 2020
  • Figure 11: India Market Segment, 2012 & 2020
  • Figure 12: APAC Market by Country, 2012 & 2020
  • Figure 13: APAC Market Value Forecast by Market Segment for MRI Systems (2011-2020), $m
  • Figure 14: Japan Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 15: Japan Installed Base of MRI Systems (2011-2020)
  • Figure 16: China Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 17: China Installed Base of MRI Systems (2011-2020)
  • Figure 18: India Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 19: India Installed Base of MRI Systems (2011-2020)
  • Figure 20: Primary Research Interviews Completed by Country
  • Figure 21: Primary Research Interviews Completed by Designation
Back to Top